The editors roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation

Vincent E. Friedewald; Gregg C. Fonarow; Brian Olshansky; Clyde W. Yancy; William C. Roberts

doi:10.1016/j.amjcard.2010.10.003

The editors roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation

Vincent E. Friedewald, Gregg C. Fonarow, Brian Olshansky, Clyde W. Yancy, William C. Roberts

Medicine, Cardiology Division

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	583-590
Number of pages	8
Journal	American Journal of Cardiology
Volume	107
Issue number	4
DOIs	https://doi.org/10.1016/j.amjcard.2010.10.003
State	Published - Feb 15 2011

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.amjcard.2010.10.003

Cite this

@article{fd88cbf298ef4638866df2085ede7a3f,

title = "The editors roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation",

author = "Friedewald, {Vincent E.} and Fonarow, {Gregg C.} and Brian Olshansky and Yancy, {Clyde W.} and Roberts, {William C.}",

note = "Funding Information: This CME activity is supported by an educational grant from Medtronic, Inc. , Minneapolis, Minnesota. Funding Information: Dr. Friedewald has received honoraria for speaking from Novartis, East Hanover, New Jersey. Dr. Fonarow has received honoraria for speaking and consulting and research grants from Medtronic; and GlaxoSmithKline, Research Triangle Park, North Carolina. Dr. Olshansky has received honoraria for speaking and consulting from Medtronic; and Boston Scientific Corporation, Natick, Massachusetts. Dr. Olshansky has received honoraria for consulting and is a member of the advisory board for Novartis. Dr. Yancy has no relevant financial relationships to disclose. Dr. Roberts has received honoraria for speaking from Merck, Whitehouse Station, New Jersey; AstraZeneca, Wilmington, Delaware; and Novartis. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",

year = "2011",

month = feb,

day = "15",

doi = "10.1016/j.amjcard.2010.10.003",

language = "English (US)",

volume = "107",

pages = "583--590",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "4",

}

The editors roundtable : Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation. / Friedewald, Vincent E.; Fonarow, Gregg C.; Olshansky, Brian; Yancy, Clyde W.; Roberts, William C.

In: American Journal of Cardiology, Vol. 107, No. 4, 15.02.2011, p. 583-590.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - The editors roundtable

T2 - Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation

AU - Friedewald, Vincent E.

AU - Fonarow, Gregg C.

AU - Olshansky, Brian

AU - Yancy, Clyde W.

AU - Roberts, William C.

N1 - Funding Information: This CME activity is supported by an educational grant from Medtronic, Inc. , Minneapolis, Minnesota. Funding Information: Dr. Friedewald has received honoraria for speaking from Novartis, East Hanover, New Jersey. Dr. Fonarow has received honoraria for speaking and consulting and research grants from Medtronic; and GlaxoSmithKline, Research Triangle Park, North Carolina. Dr. Olshansky has received honoraria for speaking and consulting from Medtronic; and Boston Scientific Corporation, Natick, Massachusetts. Dr. Olshansky has received honoraria for consulting and is a member of the advisory board for Novartis. Dr. Yancy has no relevant financial relationships to disclose. Dr. Roberts has received honoraria for speaking from Merck, Whitehouse Station, New Jersey; AstraZeneca, Wilmington, Delaware; and Novartis. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.

PY - 2011/2/15

Y1 - 2011/2/15

UR - http://www.scopus.com/inward/record.url?scp=79551671241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551671241&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2010.10.003

DO - 10.1016/j.amjcard.2010.10.003

M3 - Comment/debate

C2 - 21295175

AN - SCOPUS:79551671241

VL - 107

SP - 583

EP - 590

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 4

ER -

The editors roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this